Top Emerging Trends

Recent Posts

Glaxo to take $2.36 Billion Charge to Reflect Settlement of Most Avandia and Paxil Product Liability Cases and Other Legal Issues
Posted on 17 Jul 2010 by Tom Moylan

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and... Read More